A Study of the Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar Pustulosis
Clinical trial NCT01845987 · COMPLETED
Trial details
- NCT number
- NCT01845987
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-09-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.